Pifeltro Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

pifeltro

merck sharp & dohme b.v. - doravirine - hiv infekce - antivirotika pro systémové použití - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.

Epclusa Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

epclusa

gilead sciences ireland uc - sofosbuvir, velpatasvir - hepatitida c, chronická - antivirotika pro systémové použití - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 a 5.

Harvoni Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

harvoni

gilead sciences ireland uc - ledipasvir, sofosbuvir - hepatitida c, chronická - antivirotika pro systémové použití - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 a 5. pro virus hepatitidy c (hcv) genotypu-konkrétní aktivity viz bod 4. 4 a 5.

Tybost Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

tybost

gilead sciences ireland uc - cobicistat - hiv infekce - antivirotika pro systémové použití - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.

Vosevi Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

vosevi

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatitida c, chronická - antivirotika pro systémové použití - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (viz body 4. 2, 4. 4 a 5.

Hepcludex Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

hepcludex

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirotika pro systémové použití - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Rukobia Europeiska unionen - tjeckiska - EMA (European Medicines Agency)

rukobia

viiv healthcare b.v. - fostemsavir trometamol - hiv infekce - antivirotika pro systémové použití - rukobia, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

MAALOX 35MG/ML+40MG/ML Perorální suspenze Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

maalox 35mg/ml+40mg/ml perorální suspenze

opella healthcare czech s.r.o., praha array - 858 hydroxid hoŘeČnatÝ; 43 hydroxid hlinitÝ - perorální suspenze - 35mg/ml+40mg/ml - kombinace a komplexy slouČenin hlinÍku, vÁpnÍku a hoŘČÍku

MAALOX 400MG/400MG Žvýkací tableta Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

maalox 400mg/400mg Žvýkací tableta

opella healthcare czech s.r.o., praha array - 858 hydroxid hoŘeČnatÝ; 43 hydroxid hlinitÝ - Žvýkací tableta - 400mg/400mg - kombinace a komplexy slouČenin hlinÍku, vÁpnÍku a hoŘČÍku

MAALOX BEZ CUKRU CITRON 400MG/400MG Žvýkací tableta Tjeckien - tjeckiska - SUKL (Státní ústav pro kontrolu léčiv)

maalox bez cukru citron 400mg/400mg Žvýkací tableta

opella healthcare czech s.r.o., praha array - 30 algeldrÁt; 858 hydroxid hoŘeČnatÝ - Žvýkací tableta - 400mg/400mg - kombinace a komplexy slouČenin hlinÍku, vÁpnÍku a hoŘČÍku